Ark7
About Ark7
Ark7 is a fractional real estate investment platform that allows individuals to buy shares in income-generating rental properties across the U.S.. The company aims to democratize real estate investing, making it accessible to a wider range of investors, including non-accredited individuals, with minimum investments as low as $20. Ark7 handles the entire process from property acquisition and vetting to ongoing property management, including tenant screening, rent collection, and maintenance. This approach allows investors to earn passive income through monthly rental distributions and potential property appreciation without the traditional complexities and responsibilities of being a landlord.
The platform focuses on single-family homes, smaller multi-family units, and short-term rentals in high-growth markets. Ark7 utilizes technology and data insights to streamline investment decision-making and property operations, emphasizing transparency by providing detailed financial data and property performance updates to investors. While the initial search query indicated Ark7 as a healthcare AI company, the search results consistently describe Ark7 as a real estate investment platform. There are other companies with similar names, such as Arkangel AI and Arkstone Medical Solutions, that operate in the healthcare AI space, but Ark7 (ark7.com) is clearly focused on real estate.
What Physicians Need to Know
When considering Ark7's healthcare AI tools, physicians should focus on how the platform's no-code AI development capabilities can be leveraged to address specific clinical challenges in their practice. Evaluate the potential for improved diagnostic accuracy and efficiency, particularly in medical imaging interpretation. Consider how the real-time AI inference and visualization features can integrate into existing workflows to enhance decision-making. Physicians should also assess the platform's ability to automate repetitive tasks, freeing up time for more direct patient care. Given Ark7's emphasis on open science and global datasets, consider the potential for robust and unbiased AI models. Finally, explore the integration capabilities with existing EHR and imaging systems to ensure seamless data flow and avoid fragmented solutions.
Ark7's platform supports Docker-based models for seamless integration with existing IT infrastructure across development, testing, and production environments. This suggests a flexible approach to integrating with various healthcare systems. While specific integrations with major EHRs like Epic or Oracle Health are not detailed, the broader healthcare AI landscape emphasizes the importance of interoperability, with standards like HL7 and FHIR being crucial for data exchange. A true clinical AI platform aims for a single integration point into native systems like EHR and PACS, providing unified workflows and cross-department care coordination. Physicians should inquire about Ark7's specific integration pathways with their current electronic health record and picture archiving and communication systems to ensure optimal functionality and data utilization.
What the Web Says
Ark7 is a real estate investment platform that enables individuals to purchase fractional shares of rental properties, offering a way to earn passive income from rent and potential property appreciation without the burdens of direct property management. The platform aims to make real estate investing accessible to a broader range of investors, including those with limited capital.
Overall: MixedStrengths
- Low minimum investment, as low as $20 per share, making real estate accessible to beginners.
- Provides passive monthly income through rental distributions.
- Handles all property management, including tenant screening, maintenance, and rent collection.
- Offers transparency with detailed property information, financial breakdowns, and disclosed fees.
- Features a secondary marketplace for selling shares, offering some liquidity after a holding period.
- SEC-qualified, adding a layer of trustworthiness.
Limitations
- Limited liquidity, as the secondary marketplace may not be super active, and there's a minimum holding period (typically 12 months) before shares can be sold.
- Fees include a one-time 3% sourcing fee and an 8-15% property management fee, which some users consider high.
- Some users have reported issues with withdrawing funds or selling shares, citing a lack of a clear selling function or indefinite listing processes.
- The platform is still relatively new and has a limited track record compared to more established real estate crowdfunding platforms.
- Limited property selection compared to some alternatives.
- IRA accounts incur an annual fee of $100 per property, capped at $400 per year.
Based on reviews from: Reddit, G2, The College Investor, SparkRental, Finder, Apple App Store, WallStreetZen, The Real Estate Crowdfunding Review, Moneywise, Trustpilot, YouTube, Quora, Indeed.com, Inman, Better Business Bureau, Ark7.com
Last updated: 2026-07-02
Videos
News, demos, and interviews about Ark7.
Videos load interactively. If none appear, search YouTube for Ark7 →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]